Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination
about
Identification of New Molecular Entities (NMEs) as Potential Leads against Tuberculosis from Open Source Compound RepositoryTargeted delivery of amikacin into granuloma.Effectiveness of azithromycin in aspiration pneumonia: a prospective observational studyEvaluation of pharmacological activities, cytotoxicity and phenolic composition of four Maytenus species used in southern African traditional medicine to treat intestinal infections and diarrhoeal diseasesDesign, synthesis, and In vitro antituberculosis activity of 2(5H)-Furanone derivatives.Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy.Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria.Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease.Time-kill kinetics of antibiotics active against rapidly growing mycobacteria.Bioprospecting from cultivable bacterial communities of marine sediment and invertebrates from the underexplored Ubatuba region of Brazil.Tigecycline Potentiates Clarithromycin Activity against Mycobacterium avium In Vitro.Antituberculosis activity, phytochemical identification of Costus speciosus (J. Koenig) Sm., Cymbopogon citratus (DC. Ex Nees) Stapf., and Tabernaemontana coronaria (L.) Willd. and their effects on the growth kinetics and cellular integrity of Mycob
P2860
Q28551394-1C180141-2991-4D65-858B-7088B2E1C29FQ33652356-421ACEE9-3032-4E68-8484-EBCA13898370Q34695463-D3D7B26B-B828-43D7-90A4-FFA75450183EQ34714883-A6893B39-0F3E-46A2-AA81-8FCA8909304DQ36062032-EF624754-2A9B-46B5-AEF1-1BB88A68D9CCQ36593657-BD740527-1C29-4541-B21C-28CFF3C7FE41Q36702951-7B618E82-E98F-491E-B3A7-7D050A850C01Q38988324-290F6A14-9ABC-4637-8E2B-043B80A4993BQ39108163-003ABDED-EF12-4691-B483-BDB280E75D38Q39374577-11C803D7-35A1-42C9-82E4-BB887395DD29Q39515296-0B842722-33A1-4E4B-8C02-508DF5CA7B87Q47396139-D7DEDC7F-38BA-447F-9DD2-FE2603454888
P2860
Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Antimycobacterial agents diffe ...... , and their use in combination
@ast
Antimycobacterial agents diffe ...... , and their use in combination
@en
type
label
Antimycobacterial agents diffe ...... , and their use in combination
@ast
Antimycobacterial agents diffe ...... , and their use in combination
@en
prefLabel
Antimycobacterial agents diffe ...... , and their use in combination
@ast
Antimycobacterial agents diffe ...... , and their use in combination
@en
P2093
P2860
P1476
Antimycobacterial agents diffe ...... , and their use in combination
@en
P2093
Irma A J M Bakker-Woudenberg
Michiel A van Agtmael
Wim van Vianen
P2860
P304
P356
10.1128/AAC.49.6.2387-2398.2005
P407
P577
2005-06-01T00:00:00Z